CLL-1376: Preliminary Outcomes of Treatment in Young Patients With B-Cell Chronic Lymphocytic Leukemia and Poor Prognostic Indicators Utilizing the FCR Regimen Combined With Ibrutinib and Venetoclax in a Fixed-Duration Protocol
Evgeniy Zvonkov, Darya Koroleva, V. S. Dubov, Olga Shchetsova et autres
ru, mn (code pays fourni par la source)